Item 7.01 Regulation FD Disclosure.

aTyr Pharma, Inc. (the "Company") is participating at the Virtual Keystone Symposia: Tumor Metabolism and the Microenvironment to be held January 25-28, 2021. On January 27, 2021, the Company will present a poster entitled, "Neuropilin-2 is Expressed on Immune Cells Present in the Tumor Microenvironment, and May Contribute to the Suppression of Immune Regulation Leading to Progression and Metastasis of Cancer," and participate in a live Q&A session. The press release announcing the poster presentation is attached as Exhibit 99.1. The poster presentation has been posted on the Company's website and is attached hereto as Exhibit 99.2.

The information under this Item 7.01, including Exhibits 99.1 and 99.2 hereto, is being furnished herewith and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit No.                               Description

99.1              Press Release of aTyr Pharma, Inc. dated January 25, 2021

99.2              Poster Presentation titled "Neuropilin-2 is Expressed on
                Immune Cells Present in the Tumor Microenvironment, and May
                Contribute to the Suppression of Immune Regulation Leading to
                Progression and Metastasis of Cancer."







                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses